Christopher Nolan’s next project is an adaptation of The Odyssey, and though Oppenheimer is his biggest project to date, his ...

Oppenheimer analysts adjusted their outlook for The Hanover Insurance Group (NYSE:THG), increasing the price target from $177.00 to $185.00 while maintaining an Outperform rating on the stock. This ...

The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is ...

Oppenheimer raised the firm’s price target on Enphase Energy (ENPH) to $103 from $101 and keeps an Outperform rating on the shares. Despite a ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer has recently initiated Symbotic Inc (SYM) stock to Outperform rating, as announced on January 16, 2025, according to Finviz. Earlier, on January 13, 2025, Citigroup had resumed the stock ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...

Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...